The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis

The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis
复制标题

血管紧张素-I转换酶基因I/D变异导致接受血液透析的中国2型糖尿病患者终末期肾病风险

DOI:
10.1007/s11010-016-2819-6
复制
发表时间:
2016-09
影响因子:
4.3
通讯作者:
Jia, Weiping
Jia, Weiping
中科院分区:
生物学3区
文献类型:
--
作者:
Bao, Yuqian;Liu, Limei;Liu, Yanjun;Jia, Weiping

文献摘要

参考文献

相似文献

血管紧张素- 1转换酶(ACE)I/D变异的DD基因型是否与2型糖尿病(T2DM)终末期肾病(ESRD)风险有关仍存在争议。研究设计、病例和对照定义、样本量和种族的差异可能导致关联研究中报告的差异。我们进行了一项病例对照研究,以评估中国接受血液透析的T2DM患者的acei /D变异与ESRD风险的关系,并分析了基因型-表型的相互作用。无相关关系的中国患者(n= 432)分为非糖尿病肾病(DN)对照组(n= 222,糖尿病病程100 ~ 10年,无肾脏受累迹象)和DN-ESRD组(n= 210,因T2DM引起的ESRD,接受血液透析)。采用聚合酶链反应对所有432名受试者进行peacei /D基因型分析。DN-ESRD组ID + DD基因型的频率高于非dn对照组(65.2 vs 50.9%;调整OR为1.98 (95% CI, 1.31-3.00;P= 0.001)。在DN-ESRD组中,与II亚组相比,DD基因型亚组的HbA1c和舒张压(DBP)显著升高(均p < 0.05)。acei /D变异的DD基因型可能与更高的血压和HbA1c升高有关,因此可以预测中国血液透析T2DM患者DN-ESRD的发生、进展和严重程度。
Whether the DD genotype of the angiotensin-I converting enzyme (ACE)I/D variation contributes to end-stage renal disease (ESRD) risk in type 2 diabetes mellitus (T2DM) remains controversial. Differences in study design, case and control definition, sample size and ethnicity may contribute to the discrepancies reported in association studies. We performed a case–control study to evaluate the association of theACEI/D variation with ESRD risk in Chinese patients with T2DM receiving hemodialysis and analyzed the genotype–phenotype interaction. Unrelated Chinese patients (n= 432) were classified into the non-diabetic nephropathy (DN) control group (n= 222, duration of diabetes >10 years, no signs of renal involvement) and the DN-ESRD group (n= 210; ESRD due to T2DM, receiving hemodialysis). Polymerase chain reaction was used to genotypeACEI/D for all 432 subjects. The frequencies of the ID + DD genotypes were higher in the DN-ESRD group than non-DN control group (65.2 vs. 50.9 %; adjusted OR 1.98 (95 % CI, 1.31–3.00;P= 0.001). In the DN-ESRD group, the DD genotypic subgroup had significantly elevated HbA1c and diastolic blood pressure (DBP) compared to the II subgroup (bothP< 0.05). The DD genotype of theACEI/D variation may be associated with more elevated blood pressure and HbA1c, and therefore may predict the development, progression and severity of DN-ESRD in Chinese patients with T2DM undergoing hemodialysis.
DOI: 10.1093/ndt/gfq707
发表时间: 2011-07-01
影响因子: 6.1
作者:
Oh, Se Won;Kim, Yong Chul;Chin, Ho Jun
通讯作者: Chin, Ho Jun
DOI: 10.1111/j.1399-0004.1994.tb04210.x
发表时间: 1994-07
期刊: Clinical Genetics
影响因子: 3.5
作者:
F. Cambien
通讯作者: F. Cambien
DOI: --
发表时间: 2001-03
期刊: JOP : Journal of the pancreas
影响因子: --
作者:
V. Viswanathan;Y. Zhu;K. Bala;S. Dunn;C. Snehalatha;Ambady Ramachandran;M. Jayaraman;K. Sharma
通讯作者: V. Viswanathan;Y. Zhu;K. Bala;S. Dunn;C. Snehalatha;Ambady Ramachandran;M. Jayaraman;K. Sharma
DOI: 10.1053/j.ajkd.2012.11.031
发表时间: 2013-01-01
影响因子: 13.2
作者:
Collins, Allan J.;Foley, Robert N.;Agodoa, Lawrence
通讯作者: Agodoa, Lawrence
DOI: 10.2337/dc08-s055
发表时间: 2008-01-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
通讯作者: --